ANALYSIS METHOD OF COMBINE HARVESTERS TECHNICAL LEVEL BY FUNCTIONAL AND STRUCTURAL PARAMETERS



Efficacy and Safety of PD-1 Inhibitors Monotherapy for Elderly Patients with Advanced Non-small Cell Lung Cancer

Background Immunotherapy represented by programmed death protein-1 (PD-1) inhibitors has gradually become the standard treatment of advanced non-small cell lung cancer (NSCLC) in recent years, changing the treatment landscape of advanced NSCLC.However, most PD-1-related studies excluded patients with NSCLC more than 70 or 75 years, resulting in rel

read more